ALB and hepatocellular carcinoma: The ALBI score, derived from a patient’s albumin and total bilirubin, was originally developed in patients with hepatocellular carcinoma for the reliable assessment of liver function, and an ALBI score of >−2.60 was proposed as a prognostic indicator for mortality [6].